Skip to main content
Skip to content

Omega-3 (EPA+DHA)

Other tracked
Cardio · brain

Your intake

Today (logged)
0 mg
0% of 500 mg
Stack potential
0 mg
0% of 500 mg
Target
500 mg
Target Range
Where you are on the ladder0% of target

What each level of omega-3 (epa+dha) does

Approximate dose-response bands. Individual response varies — these are starting points, not prescriptions.

  1. Severely lowYOU ARE HERE
    0 mg165 mg

    EPA + DHA contribution to cell membranes, mood, and cardiovascular function compromised.

  2. Insufficient
    165 mg500 mg

    Most Western diets are below the AHA-suggested 500 mg/day baseline.

  3. Adequate
    500 mg750 mg

    AHA baseline (500 mg EPA+DHA) met. Good for general cardiovascular maintenance.

  4. Therapeutic
    750 mg1000 mg

    2–4 g/day used for triglyceride lowering and inflammation. Look for triglyceride-form or rTG products.

  5. Diminishing returns
    1000 mg+

    Bleeding risk at very high doses, especially with anticoagulants.

Overview

Family of polyunsaturated fatty acids: ALA (alpha-linolenic acid, plant) is the essential parent; EPA and DHA (marine) are the metabolically active long-chain forms with the strongest evidence base. Cardiovascular, neurological, and anti-inflammatory effects are well-documented; vegetarian conversion of ALA → EPA/DHA is poor (~5–10%).

Functions

  • Structural component of cell membranes (especially neural and retinal)
  • Substrate for anti-inflammatory eicosanoids (resolvins, protectins, maresins)
  • Modulates cardiac electrical stability and triglyceride synthesis
  • Required for normal fetal neural and visual development (DHA)
  • Regulates gene expression via PPAR transcription factors

Mechanism

EPA and DHA incorporate into cell membrane phospholipids, displacing arachidonic acid. Membrane EPA serves as substrate for less inflammatory series-3 prostaglandins, series-5 leukotrienes, and the resolvins/protectins/maresins that actively terminate inflammation. DHA-rich membranes (retina, brain grey matter) support fluidity and ion-channel function. Hepatic triglyceride lowering is via reduced VLDL secretion and increased fatty acid beta-oxidation.

Benefits

  • Lowers triglycerides (~25–30% at 2–4 g EPA+DHA daily)
  • Reduces sudden cardiac death and major adverse CV events (REDUCE-IT with icosapent ethyl)
  • Reduces rheumatoid arthritis joint tenderness
  • Modest reduction in mild-to-moderate depression (EPA-dominant formulas)
  • Supports fetal brain and visual development (DHA in pregnancy)
  • May reduce dry eye symptoms

Deficiency

Frank essential fatty acid deficiency is rare. Functional inadequacy is widespread — Omega-3 Index (RBC EPA+DHA % of total fatty acids) <4% associates with increased CV risk; most Western diets sit at 4–5%, ideal target ~8–11%.

Signs
  • Dry skin, eczema-like patches
  • Poor wound healing
  • Visual changes (retinal DHA depletion)
  • Cognitive symptoms, low mood
  • Increased CV risk markers
At-risk groups
  • Strict vegan diets without algae oil
  • Low fish consumption (most Western populations)
  • Premature infants
  • Cystic fibrosis, fat malabsorption

Excess

FDA GRAS up to 3 g/day from supplements (excluding diet). Higher doses (4 g+) modestly increase bleeding time and AFib incidence in REDUCE-IT and STRENGTH.

Signs
  • Increased bleeding tendency (especially with anticoagulants)
  • Fishy burps / GI upset
  • Modestly increased AFib at very high doses
  • Possible LDL increase with high-dose DHA

Forms

  • Triglyceride (TG) fish oil
    Natural form; ~50% better absorbed than ethyl ester
  • Re-esterified triglyceride (rTG)
    Concentrated and re-converted to TG form; high bioavailability
  • Ethyl ester (EE)
    Cheaper concentrate; lower bioavailability; needs higher dose
  • Phospholipid (krill oil)
    Better-absorbed at low doses; expensive per mg EPA+DHA
  • Algae oil (vegan DHA/EPA)
    Direct source, bypasses ALA conversion; the vegan option
  • Icosapent ethyl (Vascepa)
    Rx-grade pure EPA EE; the REDUCE-IT trial molecule

Food sources

  • Wild salmon (cooked) · 3 oz1,800 mg EPA+DHA
  • Sardines (canned) · 3 oz1,200 mg EPA+DHA
  • Mackerel (cooked) · 3 oz2,500 mg EPA+DHA
  • Anchovies (canned) · 2 oz1,000 mg EPA+DHA
  • Algae oil supplement · 1 capsule300–500 mg DHA
  • Ground flaxseed · 1 tbsp2,300 mg ALA (~115 mg net EPA equivalent)

Supplement forms

Triglyceride or re-esterified triglyceride (rTG) forms absorb better than ethyl ester (EE) forms. Look for products that specify EPA and DHA content per serving — total 'fish oil' mg is misleading. 1–2 g EPA+DHA daily is the typical maintenance dose. For vegan, algae-derived DHA (often paired with EPA) is the only direct route. Take with a fat-containing meal.

Bioavailability

TG form ~50% better absorbed than EE; rTG and krill oil also high. Take with a fat-containing meal (raises absorption 2–4×). Fishy burps are usually a quality (oxidation) issue — check that the product has an antioxidant (vitamin E, rosemary) and isn't past expiration. Refrigerate after opening.

Longevity relevance

Strong observational signal: higher Omega-3 Index correlates with lower all-cause and CV mortality. EPA-dominant icosapent ethyl reduced major adverse CV events 25% in REDUCE-IT. DHA supports brain structure across life. Among the cleanest cases for routine supplementation in low-fish populations.

Relationships

Synergies (works better with)
  • Vitamin E · Protects PUFAs from peroxidation; co-formulated in most fish oils
  • Astaxanthin · Carotenoid antioxidant; pairs with omega-3 for membrane protection
  • Vitamin D, K2 · Common combined cardiometabolic supplement
Antagonists (competes with / inhibited by)
  • Warfarin / antiplatelet drugs · Additive bleeding risk at >3 g/day EPA+DHA
  • Omega-6 PUFAs (very high) · Compete for desaturase enzymes; ratio matters more than absolute intake

References

About Omega-3 (EPA+DHA)

EPA+DHA — anti-inflammatory, cardiovascular, brain membrane. Target reflects common AHA/NIH guidance (no FDA DV).

Role
Cardio · brain
Daily target
500 mg (TR)
Also called
omega-3, omega 3, epa, dha, epa+dha, fish oil
Click here to learn more about Omega-3 (EPA+DHA)
Full explainer on Formulate Health — mechanisms, who's commonly deficient, food sources, evidence for supplementation.
How Omega-3 (EPA+DHA) acts on the body

The mechanisms and systems this nutrient feeds. Click any to drill into what runs on it.

Biomarkers that move with this nutrient
🩸 LDL Cholesterol🩸 HDL Cholesterol🩸 Triglycerides🩸 hs-CRP🩸 Non-HDL Cholesterol🩸 Triglyceride / HDL Ratio

★ = load-bearing / primary cofactor. Track these in My Journey.